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Studies have recently been carried out in this laboratory on the mechanism 
of tissue damage by bacterial endotoxins and by antigen-antibody interactions 
in vivo. The Arthus and Shwartzman phenomena have been used as laboratory 
models in these studies, and it has been found that the characteristic hemor- 
rhagic and necrotic cutaneous lesions which occur during the course of both of 
these phenomena are the result of thrombosis or occlusion of capillaries and 
small veins with masses of leucocytes and platelets (1, 2). Interruption of blood 
supply by the thrombi leads to necrosis of the involved vessels, followed by 
hemorrhage and destruction of the surrounding tissues. The factors contribut- 
ing  to  the  development  of  these  leucocyte-platelet thrombi  include  (a)  an 
alteration in  leucocytes and  platelets,  resulting in  a  tendency toward  intra- 
vascular aggregation of these elements, and (b) a  local alteration, in the endo- 
thelium of small blood vessels, possibly related to the development of an ab- 
normal  form of carbohydrate metabolism in  the  tissues  about  these vessels 
(2). 
It has been suggested that a  mechanism like that described above may be 
operating in the pathogenesis of certain human diseases  (2), and the present 
study was  undertaken  as  a  preliminary attempt  to  explore this  possibility. 
Pathologic material  derived from patients  succumbing  during  the  course of 
rheumatic fever and other acute and chronic diseases has been examined for 
the presence of leucocyte-platelet thrombi, and this form of vascular damage 
has been found to be regularly present in association with other histopathologic 
manifestations  of active  rheumatic  carditis.  In  the  present  communication, 
the results of this examination are presented with a  discussion of certain con- 
siderations bearing on the significance of the observations. 
Materials and Methods 
The pathologic material described in this report consisted of cardiac tissue which had been 
fixed either in formalin or in Zenker's fluid. The microscopic  sections had been stained with 
* This study was carried out during the tenure of a Life Insurance Medical Research Fund 
Fellowship. 
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TABLE I 
The Occurrence of Leucocyte-Platelet Thrombi  in the Hearts  of Patients Succumbing  during  the 
Course of Active Rheumatic  Fever 
Case 
No. 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
Classification 
Group I 
Early active rheumatic carditis 
Group II 
Chronic rheumatic carditis 
Group III 
Rheumatic heart  disease without 
evidence of active carditis 
Group IV 
Subacute  bacterial  endocarditis, 
rheumatic heart disease 
Age at  [  Year  of 
death  death 
16  1924 
19  1929 
12  1933 
16  1937 
12  1951 
12  1939 
13 
51 
10 
7 
9 
10 
17 
46 
26 
60 
28 
17 
38 
61 
55 
20 
11 
29 
45 
44 
43 
16 
23 
51 
1936 
1941 
1934 
1933 
1922 
1923 
1929 
1930 
1932 
1932 
1933 
1934 
1936 
1936 
1936 
1937 
1938 
1938 
1938 
1940 
1941 
1931 
1938 
1940 
Duration of 
disease 
14 days 
98  " 
42  " 
60  ~c 
18  " 
14  " 
3 mos. 
2 yrs. 
1 yr. 
4 mos. 
lyr. 
4 mos. 
Leuc 
cyte  platel  Aschoff 
I  thror  bodies 
i bosi 
i 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
m 
m 
N 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
m 
m 
6 mos.  +  + 
7  "  +  + 
?  --  -- 
* The thrombi observed in this case were composed 
exhibited a  severe granulocytopenia during the last 2 
course of pyramidon therapy. 
exclusively of platelets. The patient 
weeks of life,  following a  prolonged CHANDLER  A.  STETSON~  JR. 
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495 
Case 
No. 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
Classification 
Group V 
Luetic aortitis, aneurysm 
Hypertensive heart disease 
Lobar pneumonia 
Hemolytic  streptococcal  septice- 
mia 
Tuberculous meningitis 
Pulmonary tuberculosis 
Agranulocytic angina 
Lobar pneumonia 
Chronic glomerulonephritis 
Lobar pneumonia 
Myelogenous leucemia 
Lobar pneumonia 
Coronary occlusion 
Periar  teritis nodosa 
Acute bacterial endoearditis 
Thrombophlebitis 
Duration of 
disease 
6 mos. 
3 yrs. 
4 days 
5  ~¢ 
5 mos. 
3 yrs. 
14 days 
4  ~t 
6 yrs. 
4 days 
9 mos. 
9 days 
12  " 
2 yrs. 
6 days 
4  t~ 
Aschoff 
bodies 
m 
m 
m 
n 
m 
hematoxylin-eosin or with eosin-methylene blue. In some cases, the original blocks of tissue 
were available and new sections were cut and stained with Wright's stain (3), which has been 
found to provide better differentiation of the elements of leucocyte-platelet thrombi. 
The cases studied included those of all patients succumbing in this hospital since 1922  in 
which there was gross or microscopic evidence of rheumatic heart disease. The hospital records 
of these patients were examined for clinical and laboratory evidence of the presence of rheu- 
matic activity during the year preceding death. This evidence was evaluated in terms of the 
criteria suggested by Jones (4). In those cases in which active rheumatic fever was judged to 
have been present, the duration of the disease process was determined as the interval from 
the onset of the first manifestation of rheumatic activity to the time of death. The study also 
included material from patients succumbing in this hospital to diseases other than rheumatic 
fever and rheumatic heart disease.  Examination  of  the  hospital records of these  patients 
failed to reveal any evidence of rheumatic fever, and whenever possible the duration of the 
disease responsible for death was determined as above. The data obtained in this manner 
were used in the following classification of the cases studied. 
Group/.--This group consisted of six patients who succumbed during attacks of rheumatic 
fever and who exhibited definite evidence of rheumatic activity during the 2 weeks prior to 
death.  1 
Group//.--Included in this group were six patients in whom the rheumatic process was 
judged to have been inactive during the 2 weeks before death. In none of these cases were 
any of the major manifestations of rheumatic fever (4)  present during this period, although 
1 The author is indebted to Dr. May Wilson for permission to include in this group a patient 
(Case 6, Table I) on whom autopsy was performed at the New York Hospital. 496  LEUCOCYTE-PLATELET  THROMBOSIS IN RHEUMATIC CARDITIS 
in each case there had been unequivocal evidence of rheumatic activity during the year prior 
to death. 
Group III.--This group was composed of fifteen patients  suffering from rheumatic heart 
disease resulting from previous attacks of rheumatic fever. In no case was there evidence of 
active rheumatic fever during the last year of life~ 
Group IV.--This group included three patients in whom the terminal illness was subacute 
bacterial  endocarditis superimposed on rheumatic  heart disease of several years' standing, 
The infecting organism in each case was an a-hemolytic streptococcus. Because of the difficulty 
in determining  the presence or absence of coexisting rheumatic  activity in these patients, 
they were placed in a group separate from the other rheumatic patients. 
Group V.--None of the patients  in this group had a history  of rheumatic  fever, and all 
succumbed to some acute or chronic illness other than rheumatic  fever or rheumatic  heart 
disease. 
Histopathologic  examination of cardiac tissue from these patients  was carried out with 
the aim  of establishing the presence or absence of rheumatic  carditis.  The sole diagnostic 
criterion used was the presence or absence of the typical Aschoff body as described by Gross 
and Ehrlich  (5). In each case a search was also made for leucocyte-platelet thrombi of the 
type already described (1, 2). 
RESULTS 
The leucocyte-platelet thrombi observed during the course of this study were 
similar  in  general  appearance  to  those  already  shown  to  be  involved  in  the 
pathogenesis  of the  Shwartzman  and Arthus phenomena  in the rabbit.  They 
consisted of masses of platelets and leucocytes which more or less completely 
filled the lumina of the involved vessels. The proportion of leucocytes to plate- 
lets was variable, and portions of some thrombi apparently consisted exclusively 
of one or the other  of these  components.  The appearance  of thrombi typical 
of those observed in this study is illustrated  in Figs.  1 to 8. 
The vessels  most commonly found  to  be  involved were  small  veins  (Figs. 
1 to 3, 5, and 6)  and capillaries (Figs. 4 and 7), although thrombi were also ob- 
served  in occasional arterioles  (Fig.  8).  Leucocyte-platelet  thrombi were  not 
found in larger branches of the coronary arteries and veins. The thrombi were 
observed most frequently in the vessels of the myocardium and peHcardinm, 
but were also seen in the subendocardium,  in the adventitia of the aorta, and 
occasionally in valves. Figs. 1 to 4 illustrate the appearance of vessels in the peri- 
cardium of one of the patients with active rheumatic carditis (Case 5, Table I). 
In  Fig.  7  may be  seen  the  appearance  of myocardial  capillaries  containing 
similar cellular thrombi (Case 2, Table I), while Figs. 5 and 6 illustrate  leuco- 
cyte-platelet thrombosis of larger veins in the myocardinm (Case 6, Table I). 
In Table I  can be seen the correlation between the occurrence of these vas- 
cular  lesions  and  the  clinical  and  pathologic  evidence  of  active  rheumatic 
fever. In Group I, consisting of patients in whom the rheumatic process was of 
relatively short duration and of relatively severe degree at the time of death, 
leucocyte-platelet thrombosis was prominent in every case. In Group II, com- CHANDLER A. STETSON, JR.  497 
posed of patients with rheumatic fever of longer duration and of a low degree 
of activity during  the  period  of  2  weeks prior  to  death,  leucocyte-platelet 
thrombosis was found in only two cases,  and these were the only cases in this 
group which showed other histologic evidence of active rheumatic carditis. No 
leucocyte-platelet thrombi were found in the hearts of patients in Groups III 
and V,  consisting respectively of patients with rheumatic heart disease but 
with no evidence of rheumatic fever during the year preceding death and pa- 
tients with acute or chronic diseases other than rheumatic fever. In Group IV, 
consisting  of  three  patients  succumbing  to  subacute  bacterial  endocarditis 
superimposed on rheumatic heart disease, one patient  (Case 30)  showed no 
leucocyte-platelet thrombi  and  no  histopathologic  changes  characteristic  of 
active rheumatic carditis. The other two patients (Cases 28 and 29),  16 and 
23  years of age respectively, showed definite Aschoff bodies and  in both  of 
these cases leucocyte-platelet thrombi were observed. 
In none of the  cases in which leucocyte-platelet thrombi were found was 
there a  consistent correlation between the location of these thrombi and the 
location of Aschoff bodies. In general it can be stated that the thrombi were 
more frequently encountered in areas of myocardium in which Aschoff bodies 
were most numerous and less frequently found in relatively normal portions of 
the myocardium. In the pericardium, leucocyte-platelet thrombi were consist- 
ently found in  those areas showing evidence of  fresh  pericarditis,  and  fre- 
quently the thrombi appeared to be associated with small focal hemorrhages. 
DISCUSSION 
The results of this study indicate that leucocyte-platelet thrombosis of capil- 
laries and small veins is a  prominent feature of active rheumatic carditis. A 
consistent correlation was found between the occurrence of these vascular le- 
sions and the presence of Aschoff bodies in the hearts of patients dying during 
the  course  of rheumatic fever. The  significance of  this finding is  not clear. 
While it is possible that this form of vascular damage may be involved in the 
subsequent development of other more generally recognized manifestations of 
tissue damage during the course of rheumatic carditis, the limitations of the 
data and material available during this study do not permit such a conclusion. 
It is hoped that future examination of pathologic material derived from pa- 
tients earlier in the course of rheumatic fever will result in a  better under- 
standing of the sequence of events involved, and permit an evaluation of the 
significance of this vascular lesion. 
Leucocyteoplatelet thrombosis has apparently not previously been described 
in association with active rheumatic carditis. In a  survey of the vascular le- 
sions occurring during rheumatic fever, yon Glahn and Pappenheimer  (6,  7) 
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histopathologic features of rheumatic carditis, does not mention these vascular 
lesions. However, Gross, Kugel, and Epstein (9) studied lesions of the coronary 
blood vessels occurring during acute rheumatic fever and report the occasional 
finding of "granular plugged vessels." They ascribed this lesion to a prolifera- 
tion of the endothelinm of small branches of the coronary arteries,  with  sub- 
sequent granular transformation of the protoplasm.  The  appearance  of  the 
lesion in the photomicrograph which accompanies their report is quite similar 
to that of the vessel in Fig. 8. Although a complete review of the voluminous 
literature on the pathogenesis of rheumatic fever has not been attempted, no 
further  observations  bearing  on  the  leucocyte-platelet thrombosis  observed 
during this study have been found. It may be pertinent to note, however, that 
rheumatic verrucae have been shown to consist of masses of blood platelets 
with enmeshed leucocytes, erythrocytes, and strands of fibrin (8).  These ver- 
rucae, usually located along the lines of closure of valves, might thus be con- 
sidered to be parietal thrombi, and it is possible that common factors may be 
involved in the production of such deposits and in the formation of the leu- 
cocyte-platelet thrombi observed in the smaller coronary vessels. 
The mechanism whereby leucocyte-platelet thrombosis is brought about dur- 
ing the course of rheumatic carditis is not clear. The possibility has been con- 
sidered that  this phenomenon may result from some agonal or postmortem 
process.  Such  an  interpretation  seems  unlikely in view of  the  observations 
that these thrombi are not found in the larger branches of the coronary arte- 
ries and veins and are not found in the hearts of patients in the absence of 
acceptable evidence of active rheumatic carditis. In view of the fact that leu- 
cocyte-plateIet thrombi have been shown to be associated with the development 
of extensive tissue damage during the course of the Arthus and Shwartzman 
phenomena, the concept that the thrombi described above are of significance 
in the pathogenesis of rheumatic carditis may form a useful working hypothesis 
for further investigation. 
SUMMARY 
Leucocyte-platelet  thrombi, involving the smaller  branches of the coronary 
blood vessels,  have been found in the hearts  of patients  with active  rheumatic 
fever and rheumatic carditis.  A  consistent  correlation  has been observed be- 
tween the  existence  of  these  vascular  lesions  and the  presence of  typical  Aschoff 
bodies. It is suggested that these cellular  thrombi may play a role in the 
pathogenesis of rheumatic carditis. 
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EXPLANATION  OF PLATES 
The photomicrographs were  prepared by Mr. Richard Carter. 
Figs. I to 8 are  photomicrographs of  material  described  in the text  (Table I). 
PLATE 27 
FIG.  1.  Pericardium,  Case S. A small vein, with the lumen filled with erythrocytes 
and no evidence of leucocyte-platelet thrombosis. Wright's stain.  X 743. 
FIG. 2.  Pericardium, Case 5. A small vein with a mass  of platelets occupying the 
lumen. Wright's stain.  X  743. 
Fro.  3.  Pericardium, Case 5. Another small vein containing a thrombus composed 
in part of platelets and in part of leucocytes. Wright's stain.  ×  743. 
FIG.  4.  Pericardium,  Case 5. A capillary containing leucocytes and, in the upper 
portion, a mass of platelets. Wright's stain.  X 743. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  94  PLATE  27 
(Stetson: Leucocyte-platelet thrombosis in rheumatic carditis) PLATE 28 
FIC.  5.  Myocardium, Case 6. A thrombus occupies the lumen of the vein.  Higher 
magnification revealed the thrombus to be composed of platelets with numerous en- 
meshed leucocytes. Hematoxylin-eosin. ×  276. 
FIG. 6.  Myocardium, Case 6. A similar thrombus occupying the lumen of another 
vein. Hematoxylin-eosin. ×  382. 
FIG.  7.  Myocardium,  Case  4.  A  branching  capillary with  leucocytes filling the 
lumina of both branches. Wright's stain.  ×  525. 
FIG. 8.  Myocardium,  Case  2.  A  small  artery  containing  a  thrombus  composed 
mainly of platelets. The thrombus is not adherent to the endothelium, and the inter- 
vening space is occupied by erythrocytes and a few leucocytes. Eosin-methylene blue. 
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(Stetson:  Leucocyte-platelet thrombosis in rheumatic carditis) 